It works via the exact same mechanism as a chemical retinoid (so does bidens pilosa), so theyre marketing it as safer because we dont have actual studies that it isnt safe (like we do retinoids) but it makes zero sense that something that works the same way wouldnt also have the same side effects
Whether structured training programs can overcome this limitation remains to be definitively proven
Blockade of the VEGF/VEGFR signaling pathway can aggravate hypoxia resulting in the upregulation of alternative angiogenic factors such as PDGFs, FGFs, chemokines, interleukin-8 (IL-8), Delta-like ligand-4, and ephrins (Lord and Harris, 2010
By Application: T2DM dominates, Obesity growing fastest Type 2 Diabetes Mellitus maintained the dominant application position in the GLP-1 Receptor Agonist Market in 2025, driven by the large established prescriber base, comprehensive insurance coverage for diabetes indications, and the longer clinical history of GLP-1 therapy in diabetes management that has built physician comfort and treatment guideline endorsement
Understanding the pros and cons of these medications is essential for making informed treatment decisions
